3D Bioprinting Market by Technology (Laser-based, Inkjet-based, Magnetic Levitation, Syringe-based, Others), Application (Medical, Medical pills, Tissue and organ generation, Prosthetics and implants, Dental, Bioinks, Biosensors, Consumer/Personal Product Testing, Food and Animal Product), Material (Living Cells, Hydrogels, Extracellular Matrices, Others), End User & Region - Global Forecast to 2030
Report Description
The global 3D Bioprinting market size is estimated at USD 920.1 million in 2020, expanding at a CAGR 23.8% from 2021-2027 to reach 1,992.7 million USD in 2027.
3D bioprinting is a new field in the healthcare sector that is seeing rapid technological improvements, which is driving up the need for trained personnel who can run these systems successfully. Constant process monitoring is required for optimal usage of the 3D bioprinting technique. Due to uncontrollable process variables (such as batch and machine variations) and material differences, the reliability of the process differs across platforms.
Market Dynamics
The use of 3D bioprinting technology in the healthcare business has grown in recent years. Bioprinting has emerged as a potential method for fabricating artificial tissues and organs, with the potential to transform clinical analysis and medical intervention. Bioprinting companies are constantly innovating in regenerative medicine, tissue regeneration, drug therapies, and stem cell treatments, which is attracting the attention of health care providers and the drug industry who see a career with better patient care, personalized medical treatment, and a substitute to organ transplants.
Technology Segment Insights
Because it allows for the printing of complex live organs and systems on culture substrates utilizing biomaterials as bio-inks, the inkjet-based sector commanded the 3D bioprinting industry in 2020, contributing for 36.0 percent of total income. The increasing use of inkjet-based interest in the medical industry is assisting the segment's growth. This study discusses the methods of inkjet printing as a bio applicable technique, notably in the areas of tissue engineering and medication supply chain management. This market is predicted to grow considerably during the forecast timeframe due to the rising consumption and higher dependability.
Application Segment Insights
In 2020, the medical category dominated the 3D bioprinting market, accounting for 36.2 percent of total revenue. The widespread use of prescription tablets to treat a variety of chronic ailments is fueling the demand for 3D bioprinting. Furthermore, the growing demand for medications, as well as the cost-effective use of bio-drugs employing this technology, are propelling the market forward. The demand for medicinal tablets is expanding as the number of participants in the pharmaceutical sector grows. Capsules and medical pills are used by millions of individuals around the world on a daily basis. As a result, this market is likely to develop at a healthy rate over the next years.
Regional Segment Insights
In 2020, North America dominated the 3D bioprinting market, accounting for 32.4 percent of total revenue. Over the forecast period, the market is expected to rise due to the increasing adoption of IT in the healthcare industry. According to the World Meter Report 2021, there were about 23,369,732 active cases of Covid-19 recorded in the United States alone from January 13 to January 13, 2021. The government is increasing its research and development budget in an attempt to create a vaccine for this disease. As a result of this, there is a growing need for 3D bioprinting, which has been validated for drug testing and organ transplantation.
Competitive Insights
Some of the major players in this industry include 3D Systems, Inc., Stratasys Ltd, Renishaw plc, Organovo Holding Inc., GeSiM, GE Healthcare, Formlabs Inc., ExOne, EOS GmbH Electro Optical Systems, Envision TEC, Cyfuse Medical K.K, and others.
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.):
- 3D Systems, Inc.
- Stratasys Ltd
- Renishaw plc
- Organovo Holding Inc.
- GeSiM
- GE Healthcare
- Formlabs Inc.
- ExOne
- EOS GmbH
- Electro Optical Systems
- Envision TEC
- Cyfuse Medical K.K
- Others
Technology Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Laser-based
- Inkjet-based
- Magnetic Levitation
- Syringe-based
- Others
Application Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Medical
- Medical pills
- Tissue and organ generation
- Prosthetics and implants
- Dental
- Bioinks
- Biosensors
- Consumer/Personal Product Testing
- Food and Animal Product
Material Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Living Cells
- Hydrogels
- Extracellular Matrices
- Others
End User Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Research Organization
- Academic Institutes
- Biopharmaceuticals Companies
- Hospital
- Others
Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):
- North America (U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain etc.)
- Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
- South America (Brazil, Mexico, Argentina etc.)
- Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)
Table Of Content
TABLE OF CONTENT
1. 3D Bioprinting Market Overview
1.1. Product Overview and Scope of 3D Bioprinting
1.2. Global Market Growth Prospects and Revenue Estimates
1.3. Global 3D Bioprinting Market Size Growth Rate Analysis by Technology 2020 VS 2027
1.3.1. Laser-based
1.3.2. Inkjet-based
1.3.3. Magnetic Levitation
1.3.4. Syringe-based
1.3.5. Others
1.4. Global 3D Bioprinting Consumption Comparison by Application: 2020 VS 2027
1.4.1. Medical
1.4.1.1. Medical pills
1.4.1.2. Tissue and organ generation
1.4.1.3. Prosthetics and implants
1.4.2. Dental
1.4.3. Bioinks
1.4.4. Biosensors
1.4.5. Consumer/Personal Product Testing
1.4.6. Food and Animal Product
1.5. Global 3D Bioprinting Consumption Comparison by Material: 2020 VS 2027
1.5.1. Living Cells
1.5.2. Hydrogels
1.5.3. Extracellular Matrices
1.5.4. Others
1.6. Global 3D Bioprinting Consumption Comparison by End User: 2020 VS 2027
1.6.1. Research Organization
1.6.2. Academic Institutes
1.6.3. Biopharmaceuticals Companies
1.6.4. Hospital
1.6.5. Others
1.7. Global 3D Bioprinting Market Size Estimates and Forecasts by Region: 2020 VS 2027
1.7.1. North America 3D Bioprinting Estimates
1.7.2. Europe 3D Bioprinting Estimates
1.7.3. China 3D Bioprinting Estimates
1.7.4. Japan 3D Bioprinting Estimates
2. Market Competition by Manufacturers
2.1. Global 3D Bioprinting Revenue Market Share by Manufacturers (2020)
2.2. 3D Bioprinting Market Share by Company End User (Tier 1, Tier 2 and Tier 3)
2.3. Global 3D Bioprinting Average Price by Manufacturers (2016-2021)
2.4. Manufacturers 3D Bioprinting Production Sites, Area Served, Product Types
2.5. 3D Bioprinting Market Competitive Situation and Trends
2.5.1. 3D Bioprinting Market Concentration Rate
2.5.2. Mergers & Acquisitions, Expansion
3. Global 3D Bioprinting Consumption by Region (2016-2021)
3.1. Global 3D Bioprinting Consumption by Region
3.2. Global 3D Bioprinting Consumption Market Share by Region
3.2.1. North America
3.2.2. North America 3D Bioprinting Consumption Growth Rate (2016-2021)
3.2.3. North America 3D Bioprinting Consumption, Price and Gross Margin (2016-2021)
3.2.4. North America 3D Bioprinting Consumption by Country
3.2.4.1. U.S.
3.2.4.2. Canada
3.2.5. Europe
3.2.6. Europe 3D Bioprinting Consumption Growth Rate (2016-2021)
3.2.7. Europe 3D Bioprinting Consumption, Price and Gross Margin (2016-2021)
3.2.8. Europe 3D Bioprinting Consumption by Country
3.2.8.1. Germany
3.2.8.2. U.K.
3.2.8.3. France
3.2.8.4. Italy
3.2.8.5. Spain
3.2.9. Asia Pacific
3.2.10. Asia Pacific 3D Bioprinting Consumption Growth Rate (2016-2021)
3.2.11. Asia Pacific 3D Bioprinting Consumption, Price and Gross Margin (2016-2021)
3.2.12. Asia Pacific 3D Bioprinting Consumption by Country
3.2.12.1. China
3.2.12.2. India
3.2.12.3. Japan
3.2.12.4. Indonesia
3.2.12.5. Malaysia
3.2.12.6. Australia
3.2.12.7. South Korea
3.2.13. South America
3.2.14. South America 3D Bioprinting Consumption Growth Rate (2016-2021)
3.2.15. South America 3D Bioprinting Consumption, Price and Gross Margin (2016-2021)
3.2.16. South America 3D Bioprinting Consumption by Country
3.2.16.1. Brazil
3.2.16.2. Mexico
3.2.16.3. Argentina
3.2.17. Middle East and Africa
3.2.18. Middle East and Africa 3D Bioprinting Consumption Growth Rate (2016-2021)
3.2.19. Middle East and Africa 3D Bioprinting Consumption, Price and Gross Margin (2016-2021)
3.2.20. Middle East and Africa 3D Bioprinting Consumption by Country
3.2.20.1. Saudi Arabia
3.2.20.2. Kuwait
3.2.20.3. UAE
3.2.20.4. South Africa
4. Global 3D Bioprinting Consumption by Technology (2016-2021)
4.1. Global 3D Bioprinting Price by Technology (2016-2021)
4.2. Global 3D Bioprinting Revenue Market Share by Technology (2016-2021)
4.2.1. Laser-based
4.2.2. Inkjet-based
4.2.3. Magnetic Levitation
4.2.4. Syringe-based
4.2.5. Others
5. Global 3D Bioprinting Consumption by Application (2016-2021)
5.1. Global 3D Bioprinting Price by Application (2016-2021)
5.2. Global 3D Bioprinting Revenue Market Share by Application (2016-2021)
5.2.1. Medical
5.2.1.1. Medical pills
5.2.1.2. Tissue and organ generation
5.2.1.3. Prosthetics and implants
5.2.2. Dental
5.2.3. Bioinks
5.2.4. Biosensors
5.2.5. Consumer/Personal Product Testing
5.2.6. Food and Animal Product
6. Global 3D Bioprinting Consumption by Material (2016-2021)
6.1. Global 3D Bioprinting Price by Material (2016-2021)
6.2. Global 3D Bioprinting Revenue Market Share by Material (2016-2021)
6.2.1. Living Cells
6.2.2. Hydrogels
6.2.3. Extracellular Matrices
6.2.4. Others
7. Global 3D Bioprinting Consumption by End User (2016-2021)
7.1. Global 3D Bioprinting Price by End User (2016-2021)
7.2. Global 3D Bioprinting Revenue Market Share by End User (2016-2021)
7.2.1. Research Organization
7.2.2. Academic Institutes
7.2.3. Biopharmaceuticals Companies
7.2.4. Hospital
7.2.5. Others
8. Key Companies Profiled
8.1. 3D Systems, Inc.
8.1.1. 3D Systems, Inc. 3D Bioprinting Corporation Information
8.1.2. 3D Systems, Inc. 3D Bioprinting Product Portfolio
8.1.3. 3D Systems, Inc. 3D Bioprinting Consumption, Price and Gross Margin (2016-2021)
8.1.4. 3D Systems, Inc. Main Business and Markets Served
8.1.5. 3D Systems, Inc. Recent Developments/Updates
8.2. Stratasys Ltd
8.3. Renishaw plc
8.4. Organovo Holding Inc.
8.5. GeSiM
8.6. GE Healthcare
8.7. Formlabs Inc.
8.8. ExOne
8.9. EOS GmbH
8.10. Electro Optical Systems
8.11. Envision TEC
8.12. Cyfuse Medical K.K
8.13. Others
9. Marketing Channel, Distributors and Customers
9.1. Marketing Channel
9.2. 3D Bioprinting Distributors List
9.3. 3D Bioprinting Customers
10. Market Dynamics
10.1. 3D Bioprinting Industry Trends
10.2. 3D Bioprinting Growth Drivers
10.3. 3D Bioprinting Market Challenges
10.4. 3D Bioprinting Market Restraints
11. Global 3D Bioprinting Consumption and Demand Forecast, by Region (2022-2027)
11.1. Global Forecasted Demand Analysis of 3D Bioprinting, by Regions and Country
11.1.1. North America Forecasted Consumption of 3D Bioprinting by Country
11.1.2. Europe Market Forecasted Consumption of 3D Bioprinting by Country
11.1.3. Asia Pacific Market Forecasted Consumption of 3D Bioprinting by Region
11.1.4. Latin America Forecasted Consumption of 3D Bioprinting by Country
11.1.5. Middle East and Africa Forecasted Consumption of 3D Bioprinting by Country
12. Global 3D Bioprinting Consumption and Demand Forecast, by Technology Segments (2022-2027)
12.1. Global Forecasted Consumption of 3D Bioprinting by Technology Segments (2022-2027)
12.2. Global Consumption and Price Forecast by Technology Segments (2022-2027)
12.3. Global Forecasted Growth Rate of 3D Bioprinting by Technology Segments (2022-2027)
13. Global 3D Bioprinting Consumption and Demand Forecast, by Application Segments (2022-2027)
13.1. Global Forecasted Consumption of 3D Bioprinting by Application Segments (2022-2027)
13.2. Global Consumption and Price Forecast by Application Segments (2022-2027)
13.3. Global Forecasted Growth Rate of 3D Bioprinting by Application Segments (2022-2027)
14. Global 3D Bioprinting Consumption and Demand Forecast, by Material Segments (2022-2027)
14.1. Global Forecasted Consumption of 3D Bioprinting by Material Segments (2022-2027)
14.2. Global Consumption and Price Forecast by Material Segments (2022-2027)
14.3. Global Forecasted Growth Rate of 3D Bioprinting by Material Segments (2022-2027)
15. Global 3D Bioprinting Consumption and Demand Forecast, by End User Segments (2022-2027)
15.1. Global Forecasted Consumption of 3D Bioprinting by End User Segments (2022-2027)
15.2. Global Consumption and Price Forecast by End User Segments (2022-2027)
15.3. Global Forecasted Growth Rate of 3D Bioprinting by End User Segments (2022-2027)
16. Research Finding and Conclusion
17. Methodology and Data Source
17.1. Methodology/Research Approach
17.1.1. Research Programs/End User
17.1.2. Market Size Estimation
17.1.3. Market Breakdown and Data Triangulation
17.2. Data Source
17.2.1. Secondary Sources
17.2.2. Primary Sources
17.3. Author List
17.4. Disclaimer
Research Methodology
Our research studies are primarily performed in five phases which include Secondary Research, Primary Research, Subject Matter Expert Advice, Quality Check, and Final Review. The process opted for conducting thorough research to make authentic business reports is briefly described below-
Secondary Research-
- Based on the understanding of requirements, we conducted secondary research to identify the Segment specifications, qualitative and quantitative data along with the factors responsible for the growth of the market.
- The secondary sources referred for the study include press releases, company annual reports, and research papers related to the industry.
- Various sources such as industry magazines, trade journals, government websites, and associations were also reviewed for gathering precise analysis on opportunities for business expansions in the market.
- Moreover, quantitative as well as qualitative data were also extracted from paid databases, which included Reuters, Factiva, Bloomberg, One Source, and Hoovers, which proved to be useful for in-depth technical study of the market.
Primary Research-
- The research carried out during the desk research was verified by primary interviews. Primary research was scheduled with a number of industry experts for conducting telephonic interviews, and also our team send questionnaires through their official emails.
- The secondary data collected was then verified by various industry participants which included Segment managers, marketing managers, VPs, CEOs, purchasing managers, subject matter experts.
- An interview with the mentioned participants aids invalidation of our research findings regarding the Segment.
- It helps in the provision of first-hand data on factors such as market size, growth, regional trends, market trends, and competition in the industry. This approach makes our findings precise in order to help our clients in strategic decision-making processes.
Subject Matter Advice-
- The secondary and primary research key findings were then validated by the in-house subject matter experts having extensive experience in the market research industry.
- Specific requirements of the clients were reviewed by the experts to check for completion of the market study. Experts help in channelizing the representation skills of the analyst in terms of providing data that can be easily understood by our customers.
Quality Check-
- The analysis done by the research team was further reviewed to check for data accuracy provided to suit the clients’ specific requirements.
- This revision was done in various phases to check the data authenticity and to remove negligible errors in the final compilation.
Final Review-
- After the quality check, a final review of the report was done to look after the presentation, formatting, and to recheck if all the requirements of the clients were addressed. The next phase remains dispatch of the report to the client.
Enquire Before Purchase
Frequently Asked Questions
Why Choose Market Research Strategy?
We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports
We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround
Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.
We abide by the information security policy and adheres to keep your private and business information confidential and secure.